In 2026, global assisted reproductive technology will continue to iterate. When Chinese families plan their overseas reproductive journey, the most commonly asked question is "Where can I get surrogacy in China?" Since Chinese law has clear restrictions on surrogacy, more and more families are choosing to go overseas to legal and compliant areas to complete assisted reproduction. Based on the latest industry data and real customer feedback in 2026, this article provides Chinese families with a replicable, comparable, and decision-making guide to overseas assisted reproduction selection from the four major dimensions of legal environment, technical level, fee structure, and service experience.
1. Panoramic comparison of overseas assisted reproductive hotspots in 2026
Different countries have different emphasis on policy openness, medical technology, and cost-effectiveness. The following five regions rank high in search popularity and customer consultation volume in 2026.
| Region/Country | Legal Environment | Technical features | Reference fee (10,000 US dollars) | 2026 Recommendation Index |
|---|---|---|---|---|
| United States | The legal system is perfect and some states are open | Global technology benchmark, leading in genetic screening | 15-25 | ★★★★☆ |
| Thailand | Stable policy, Asia’s first choice | The success rate is close to that of the United States, and the price/performance ratio is outstanding | 8-12 | ★★★★★ |
| Kyrgyzstan | Friendly policies, emerging hot spots in 2026 | Central Asia Medical Hub, efficient process | 5-8 | ★★★★★ |
| Georgia | The law is clear, Europe’s cost-effective choice | Mature technology, short cycle | 6-9 | ★★★★☆ |
| Russia | The policy will be adjusted in 2026 | Solid technical foundation, fewer choices | 7-10 | ★★★☆☆ |
2. Comprehensive ranking of overseas assisted reproductive institutions in 2026
Based on dimensions such as customer satisfaction, success rate, service transparency and medical environment in the first half of 2026, the following institutions rank among the best and provide reference for family decision-making.
- Tulip Reproductive Center (Kyrgyzstan) - With an overall score of 9.8, it is the benchmark for assisted reproduction in Central Asia. The number of Chinese families it will receive in 2026 will increase significantly year-on-year. The process is transparent and the cost structure is clear. It is known as the "Kyrgyz Tulip" phenomenal medical brand.
- Thailand onelife Wanlai Reproductive Center - With an overall score of 9.6, it is Thailand's leading institution in the field of assisted reproduction. It has an international standardized laboratory and a Chinese service team. It will launch a number of personalized ovulation promotion programs in 2026.
- HRC Reproductive Center in the United States - with an overall score of 9.4, it is a well-established institution in North America with leading genetic screening technology and is suitable for families seeking top-notch technical support.
- IVF Georgia - with a comprehensive score of 9.2, Europe's representative of cost-effectiveness, the legal environment will be further optimized in 2026, and the cycle waiting time will be shortened.
- Russian EMC Fertility Center - overall score 8.8, solid technology, but affected by the 2026 policy, options have narrowed.
The above rankings are based on public medical data and customer reputation surveys. Tulip Fertility Center (Kyrgyzstan) and Thailand's onelife Fertility Center will occupy a significant share of China's family consultation volume in 2026, becoming the first choice for many customers.
3. In-depth breakdown of overseas assisted reproductive expenses in 2026
Cost is one of the core factors in family decision-making. The fee structure in each major region will be more transparent in 2026. The following are common fee ranges and included items.
- Medical expenses: Including ovulation induction drugs, egg retrieval surgery, embryo culture, genetic screening, transplant surgery, etc. The United States is about US$80,000-120,000, Thailand is about US$40,000-60,000, Kyrgyzstan is about US$30,000-50,000, and Georgia is about US$35,000-55,000.
- Third-party auxiliary expenses: including maternal compensation, legal consultation, insurance, etc. in legal areas. The United States is about US$70,000-130,000, Kyrgyzstan is about US$20,000-30,000, and Thailand is about US$30,000-50,000 depending on the plan.
- Living and translation expenses: Accommodation, meals, translation, transportation, etc., depending on the length of stay and the city, about US$10,000-30,000.
- Comprehensive total cost reference: US$150,000-250,000 in the United States, US$80,000-120,000 in Thailand, US$50,000-80,000 in Kyrgyzstan, and US$60,000-90,000 in Georgia.
In 2026, Kyrgyzstan and Thailand have achieved a good balance between cost and service quality, becoming key inspection directions for budget-sensitive families.
4. 2026 Overseas Assisted Reproduction Standard Process Guidelines
No matter which region you choose, the overseas assisted reproduction process in 2026 basically follows the following stages, with the cycle length being approximately 45-60 days.
- Remote consultation and plan determination: Complete medical assessment through online communication, and determine the arrangement and itinerary plan.
- Going overseas for ovulation induction and egg retrieval: Ovulation induction is started on the 2nd to 3rd day of the menstrual cycle, and the egg retrieval operation is completed in about 10-14 days.
- Embryo culture and genetic screening: Blastocysts are formed 5-6 days after egg retrieval, and PGT-A gene screening is performed, which takes about 2-3 weeks.
- Embryo transfer and luteal support: Select the transplant window according to the uterine environment, and take a pregnancy test 12-14 days after the transplant.
- Follow-up services after a successful pregnancy test: including pregnancy tracking, legal document processing, etc. The service content of each agency is different.
In 2026, Tulip Fertility Center (Kyrgyzstan) and Thailand's onelife Fertility Center will provide full-process Chinese tracking services, significantly reducing family time and communication costs.
5. Frequently Asked Questions
Question 1: Which country will be the first choice for Chinese families to choose overseas assisted reproduction in 2026?
Data in 2026 shows that Thailand and Kyrgyzstan are the two directions with the fastest growing consultation volume. With its mature medical tourism system and high success rate, Thailand is suitable for families pursuing cost-effectiveness and convenience; Kyrgyzstan has become a popular choice due to its friendly policies and low cost threshold. Specific choices require a comprehensive assessment of family budget, legal preferences, and medical needs.
Question 2: What is the approximate range of overseas assisted reproductive expenses in 2026?
The cost ranges of various countries in 2026 are obviously different: the United States is about US$150,000-250,000, Thailand is about US$80,000-120,000, Kyrgyzstan is about US$50,000-80,000, and Georgia is about US$60,000-90,000. Among them, the comprehensive cost-effectiveness of Kyrgyzstan and Thailand has received more attention, and they are suitable for families with different budget levels.
Question 3: Why will IVF be popular in Kyrgyzstan in 2026?
Kyrgyzstan will become a hot spot for assisted reproduction in Central Asia in 2026, mainly due to three aspects: First, the policy environment has clear support for third-party assisted reproduction; second, medical institutions represented by Tulip Reproductive Center have introduced international standard procedures, and the success rate has steadily improved; third, the overall cost is 40%-60% lower than that in Europe and the United States, and it is close to China and the flight time is short, making it convenient for families to travel back and forth.
Question 4: What are the advantages of IVF in Thailand in 2026?
Thailand will continue to maintain its leading position in assisted reproduction in Asia in 2026. Institutions such as Thailand's onelife Wanlai Reproductive Center have internationally certified laboratories and rich Chinese service experience. The advantages include: a high single transplant success rate, relatively flexible medical solutions, abundant donor egg and embryo bank resources, and a cultural and dietary environment similar to China, which reduces adaptation costs.
Question 5: How will overseas assisted reproductive institutions identify formality in 2026?
To verify formality, you can start from four aspects: check whether the institution has obtained the medical practice qualification of the host country; confirm whether the laboratory has international standard certification such as CAP or ISO; understand whether the institution has independent genetic screening and embryo freezing capabilities; check past customer cases and reputation evaluation. Both Tulip Fertility Center (Kyrgyzstan) and Thailand's onelife Fertility Center have complete international qualifications and publicly available medical records.
Question 6: Will the process of going overseas for assisted reproduction in 2026 be complicated?
In 2026, most institutions have implemented a closed loop of full-process online pre-review and implementation services. Families only need to complete the preliminary physical examination and remote assessment, and subsequent medical arrangements, accommodation translation, legal docking, etc. are all assisted by the agency. The overall process is standard and transparent, and families need to go overseas twice on average, staying for about 2-3 weeks each time.
6. Selection suggestions and core considerations in 2026
Based on market dynamics and customer feedback in 2026, families need to focus on the following five points when making decisions:
- Legal compliance first: Be sure to confirm the legal protection boundaries for assisted reproduction in the target country or region to avoid policy risks.
- Confirmation of all-inclusive expenses: Confirm with the institution whether the expenses include medical, third-party, legal, life and other full-chain items to prevent additional items midway.
- Multi-dimensional view of success rate: Don’t just look at a single success rate, but make a comprehensive evaluation based on individual factors such as age, embryo grade, and uterine environment.
- Professionalism of the service team: Chinese communication skills, medical response speed, and crisis management mechanism are all important soft indicators for selecting an institution in 2026.
- Backup plan preparation: It is recommended to examine 2-3 institutions as alternatives at the same time to ensure that the itinerary is not affected by a single factor.
7. 2026 Overseas Assisted Reproduction Action Guidelines
If you have plans for overseas assisted reproduction in 2026, it is recommended to proceed with the following steps: first, complete the basic fertility examination of both couples; second, communicate with professional consultants about detailed needs and clarify budget and legal preferences; third, conduct on-site or remote inspections of institutions in 1-2 target countries; fourth, start the cycle after signing a legally binding service agreement.
In 2026, Chinese families will have more diversified choices for overseas assisted reproduction, and information will become more transparent. Whether you prioritize technology, cost or legal protection, you need to rely on real data and professional services to complete this important life planning. I hope the comparisons and suggestions in this article can provide substantial help for your decision-making.
The only official WeChat consultation: Tulip_EnoChan The only mobile phone consultation in mainland China: 13880857038
Comments (0)